Anixa Biosciences Inc. (NASDAQ: ANIX)
$3.22
+0.4500 ( +16.25% ) 235.7K
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Market Data
Open
$3.22
Previous close
$2.77
Volume
235.7K
Market cap
$103.06M
Day range
$2.71 - $3.29
52 week range
$2.15 - $5.13
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 48 | Mar 22, 2024 |
4 | Insider transactions | 1 | Mar 15, 2024 |
4 | Insider transactions | 1 | Mar 15, 2024 |
10-q | Quarterly Reports | 60 | Mar 12, 2024 |
def | Proxies and info statements | 3 | Feb 08, 2024 |
4 | Insider transactions | 1 | Jan 16, 2024 |
4 | Insider transactions | 1 | Jan 16, 2024 |
4 | Insider transactions | 1 | Jan 16, 2024 |
10-k | Annual reports | 63 | Jan 16, 2024 |
4 | Insider transactions | 1 | Jan 16, 2024 |